Archives

BioStock published an article on 26 November 2020 about Aptahem, which can be read in full below. Biotechnology company Aptahem, that develops its drug candidate Apta-1 for the treatment of [...]

Aptahem AB (publ), announce today that the company enters a collaboration agreement with the German company Granzer Regulatory Consulting and Services to prepare for applications to the European [...]

BioStock published an article on 15 October 2020 about Aptahem, which can be read in full below. On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a [...]

Aptahem AB (publ), announce today that the Chairman of the Board of Directors, Kjell G Stenberg, has requested his own resignation from the Board. Due to this, the Board of Directors will call [...]

Aptahem AB, a leading developer of aptamer-based drugs, announced today that the company is now starting large-scale manufacturing after LGC Bioresearch Technologies Inc. (LGC) completed the [...]

BioStock published an article on 10 July 2020 about Aptahem, which can be read in full below. Last night, Malmö-based Aptahem announced that they have entered a preclinical collaboration with the [...]

Aptahem (publ) today announced the beginning of a collaboration with the University Health Network, a research hospital affiliated with University of Toronto in Canada. The collaboration aims to [...]

BioStock published an article on 1 July 2020 about Aptahem, which can be read in full below. At the end of last year, Aptahem entered a consortium with Örebro University with the aim of [...]

Aptahem (publ) is a biotech company developing aptamer-based pharmaceuticals for the treatment of life-threatening conditions, such as sepsis. A similar mechanism occurs in cardiovascular [...]

BioStock published an article on 24 June 2020 about Aptahem, which can be read in full below. For half a century Dexamethasone has been used to treat diseases such as rheumatoid arthritis and [...]